April « 2011 « Health Headlines Explained™

Causes for resistance to melanoma drugs

Melanoma, cancer of the melanin-producing cells typically found in skin, is very difficult to treat and often fatal. Patients tend to respond to therapies that shut down a pro-cell growth pathway by activating a bypass pathway. PLX4032 is a promising experimental new cancer drug in phase III clinical trials for treatment of melanoma. [...]

Category: Cancer

HHE App

Dr. Blanck is a professor at the University of South Florida College of Medicine. However, the content of these web pages does not represent any kind of endorsement by the University of South Florida, and the content is solely the property of University Seminar Associates, Inc.

©2009,2010 University Seminar Associates, Inc.

No information provided by Health Headlines Explained web pages is intended to be a recommendation for care; an endorsement of a product, procedure or drug; or a substitute for consulting a health care professional. The information is provided for educational purposes only. Individual patients should seek medical care and guidance, that is appropriate for their specific situation, from a licensed health care professional. Furthermore, the synopses and responses to emailed questions represent the opinions of qualified medical college faculty authors but may not reflect the view of any medical college or other employer.

Powered by WordPress | Developed by Fountain Dew